Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 46: 976-988, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (79)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Owen, R. W.
Right arrow Articles by Bartsch, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Owen, R. W.
Right arrow Articles by Bartsch, H.
(Clinical Chemistry. 2000;46:976-988.)
© 2000 American Association for Clinical Chemistry, Inc.


Nutrition

Identification of Lignans as Major Components in the Phenolic Fraction of Olive Oil

Robert W. Owen1,a, Walter Mier2, Attilio Giacosa4, William E. Hull3, Bertold Spiegelhalder1 and Helmut Bartsch1

1 Division of Toxicology and Cancer Risk Factors,
2 Division of Molecular Toxicology, and
3 Central Spectroscopy Department, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.

4 National Institute of Cancer Research, 16132 Genoa, Italy.
a Author for correspondence. Fax 49-6221-42-3359; e-mail r.owen{at}dkfz-heidelberg.de


Abstract

Background: Because olive oil is an important component of the Mediterranean diet, it is necessary to establish unequivocal identification of the major potential antioxidant phenolic compounds it contains.

Methods: The major phenolic antioxidants in extra virgin olive oil were isolated and purified. Structural analysis was conducted using several spectroscopic techniques, including mass spectrometry and nuclear magnetic resonance (NMR). In particular, detailed 1H and 13C NMR data are presented, and several assignment errors in the literature are corrected.

Results: The data show for the first time that the lignans (+)-1-acetoxypinoresinol and (+)-pinoresinol are major components of the phenolic fraction of olive oils. These lignans, which are potent antioxidants, are absent in seed oils and virtually absent in refined virgin oils but are present at concentrations of up to 100 mg/kg (mean ± SE, 41.53 ± 3.93 mg/kg; range, 0.65–99.97 mg/kg) in extra virgin oils. As with the simple phenols and secoiridoids, there is considerable interoil variation in lignan concentrations. Foods containing high amounts of lignan precursors have been found to be protective against breast, colon, and prostate cancer.

Conclusion: Lignans, as natural components of the diet, may be important modulators of cancer chemopreventive activity.




The following articles in journals at HighWire Press have cited this article:


Home page
J. Nutr.Home page
R. Fabiani, A. De Bartolomeo, P. Rosignoli, M. Servili, R. Selvaggini, G. F. Montedoro, C. Di Saverio, and G. Morozzi
Virgin Olive Oil Phenols Inhibit Proliferation of Human Promyelocytic Leukemia Cells (HL60) by Inducing Apoptosis and Differentiation
J. Nutr., March 1, 2006; 136(3): 614 - 619.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. Hagenlocher, J. Nair, N. Becker, A. Korfmann, and H. Bartsch
Influence of Dietary Fatty Acid, Vegetable, and Vitamin Intake on Etheno-DNA Adducts in White Blood Cells of Healthy Female Volunteers: A Pilot Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1187 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. C. Iliou, C. Fumeron, M. O. Benoit, P. Tuppin, C. L. Courvoisier, V. M. Calonge, N. Moatti, C. Buisson, and C. Jacquot
Factors associated with increased serum levels of cardiac troponins T and I in chronic haemodialysis patients: Chronic Haemodialysis And New Cardiac Markers Evaluation (CHANCE) study
Nephrol. Dial. Transplant., July 1, 2001; 16(7): 1452 - 1458.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.